Takeda Pharmaceutical Company Limited
Heterocyclic compound
Last updated:
Abstract:
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
24 Aug 2016
Issue date:
10 Sep 2019